Report overview
Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines.
This report contains market size and forecasts of Bacterial Vaccines in Global, including the following market information:
Global Bacterial Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bacterial Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsular Polysaccharide Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bacterial Vaccines include Pfizer, Merck, GlaxoSmithKline, Sanofi, PaxVax, Serum Institute of India and Emergent BioDefense Operations Lansing, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bacterial Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacterial Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bacterial Vaccines Market Segment Percentages, by Type, 2021 (%)
Capsular Polysaccharide Vaccines
Toxoid Vaccines
Purified Protein Vaccines
Live Attenuated Bacterial Vaccines
Killed Bacterial Vaccines
Others
Global Bacterial Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bacterial Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Bacterial Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bacterial Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacterial Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bacterial Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
GlaxoSmithKline
Sanofi
PaxVax
Serum Institute of India
Emergent BioDefense Operations Lansing
